Corient Private Wealth’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Corient Private Wealth's RYTM Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 21,943 shares worth $2.09M. The stake represents ﹤0.01% of the portfolio and ranks #1599 among its holdings.
334 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Corient Private Wealth held 21,943 shares of Rhythm Pharmaceuticals worth $2.09M as of Q3 2026.
- Rhythm Pharmaceuticals was a new Corient Private Wealth position in Q3 2026.
- Rhythm Pharmaceuticals made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #1599 holding.
- 334 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.